Mounjaro and Ramadan: making the right decision for your fast

How Ramadan's eating window changes what Mounjaro is doing

Mounjaro works partly by slowing the rate at which food leaves the stomach and by reducing the appetite signals your brain receives. In everyday life, that means smaller portions feel satisfying and hunger between meals is blunted. During Ramadan, food and drink are restricted to the hours between Iftar (the evening meal breaking the fast) and Suhoor (the pre-dawn meal). The medicine does not pause at dawn, it continues acting across both the fasting window and the eating window, which are now compressed into a very different daily shape.

The practical consequence is that nausea, the side effect people most often notice when they start Mounjaro or move up a dose, can feel sharper when the stomach is empty for long stretches. Some people find that eating less at Suhoor to manage Mounjaro-related discomfort leaves them more depleted by mid-afternoon. That is not a reason to stop, but it is worth anticipating and discussing. The Mounjaro overview on this site covers what the medicine does more broadly, if you want that context first.

Fluid intake is the other variable that matters. Mounjaro-related gastrointestinal side effects can cause the body to lose fluids faster than usual, and during a fast there is no opportunity to top them up until Iftar. Staying well hydrated across the non-fasting hours is genuinely important, not a minor footnote.

The injection timing question: can you shift the day?

Because Mounjaro is once weekly, there is some flexibility in which day you inject. Some people on weekly injections shift their injection day to fall at Iftar, reasoning that food in the stomach and adequate hydration at that moment may reduce nausea. This is not a medically prohibited step in principle, but it is also not one you should make quietly on your own, moving the injection day requires your prescriber's input, particularly if you are mid-titration or on a higher dose where side effects are more pronounced.

The same logic applies to anyone thinking about a temporary pause. Stopping and restarting a GLP-1 medicine is not automatically harmful, but it does change how your appetite behaves in the intervening weeks, and restarting after a gap can bring a return of early side effects. Your prescriber is the right person to weigh that against the benefits of fasting unencumbered by the medicine. If you have noticed an elevated heart rate alongside other symptoms, our page on tirzepatide tachycardia explains what is known and when to seek advice.

People who are also managing other health conditions, or who take other regular medicines, add another layer. Our page on Mounjaro and ramipril is an example of how specific combinations require their own clinical assessment; the same principle applies to any co-prescription. If you are taking an opioid painkiller alongside your weight-loss treatment, our guidance on Mounjaro and tramadol explains the particular considerations that apply to that combination.

Type 2 diabetes and Ramadan: a separate, more urgent conversation

Mounjaro is licensed both for weight management and for type 2 diabetes. If you are taking it for diabetes, fasting during Ramadan carries risks well beyond nausea and timing, blood glucose can become unpredictable, and hypoglycaemia (or hyperglycaemia) is a genuine concern during long fasting windows. NHS guidance is explicit that people with diabetes who plan to fast should discuss it with their diabetes team in advance of Ramadan, not during it. That conversation should happen weeks beforehand, not the night before the month starts. The NHS's tirzepatide medicines page outlines the known side effects and precautions that are particularly relevant in this context.

If you are taking Mounjaro for weight management only and do not have diabetes, the blood glucose dimension is less acute, but dehydration, electrolyte shifts and GI side effects still warrant a review of your current dose and timing. That conversation is easier to have early. Fasting is not a medical emergency in itself; combining it with an active prescription without any clinical input can make it harder than it needs to be. It is also worth knowing that some people using Mounjaro for weight loss have questions about other aspects of their health during treatment, and our page on Mounjaro and erectile dysfunction addresses one topic that comes up more often than people might expect.

What a prescriber needs to know before you fast

The most practical thing you can do before Ramadan begins is raise it at your next clinical review, or contact your prescribing service specifically. A prescriber considering your Ramadan plans will want to know: your current dose, how well you have tolerated it so far, whether you have any conditions that affect fluid balance or blood glucose, and what other medicines you are taking. That is a short conversation with a large practical payoff.

If you are sourcing Mounjaro through a private service, the same principle applies. Our FAQs cover how follow-up and aftercare work, and our dedicated Mounjaro during Ramadan page goes deeper into the week-by-week management questions some people want answered. For anything beyond standard FAQ territory, our contact page reaches the team directly. Treatment pricing and what is included in a private prescription are covered on our weight-loss treatments page.

The MHRA's Yellow Card scheme is also worth knowing about: if you notice an unexpected reaction during fasting (something you have not experienced before on Mounjaro) you can report it there, as well as raising it with your prescribing team. It all feeds into the ongoing safety picture for GLP-1 medicines in the UK. For a broader look at weight management options, our weight-loss treatments overview sets out what is currently available through a private prescription.